| CL2888A |
|
905854-03-7 |
(3S,4S)-替万替尼
(3S,4S)-Tivantinib | 3S,4S)-ARQ 197 | ARQ 198
-
98+%
|
需询价 |
C23H19N3O2 |
|
|
|
| CL2884 |
|
936091-14-4 |
|
需询价 |
C26H35N7O2S |
|
|
|
| CL1006C |
|
2109414-84-6 |
拉格鲁西布二盐酸盐 | CHIR-99021二盐酸盐 |
Laduviglusib dihydrochloride | CHIR-99021 dihydrochloride | CT99021 dihydrochloride
-
98+%
|
需询价 |
C22H18Cl2N8·2HCl |
|
|
|
| CL2733A |
|
2109704-99-4 |
甲磺酸贝舒地尔
Belumosudil mesylate (KD025 mesylate; SLx-2119 mesylate)
-
98+%
|
需询价 |
C27H28N6O5S |
|
|
|
| CL2709 |
|
1422144-42-0 |
奈舒地尔甲磺酸盐
Netarsudil dimesylate ( AR-13324 dimesylate)
-
98+%
|
需询价 |
C30H35N3O9S2 |
|
|
|
| CL2247A |
|
2050057-56-0 |
乌帕替尼半水合物
Upadacitinib hemihydrate
-
98+%
|
需询价 |
C34H40F6N12O3 |
|
|
|
| CL2693 |
|
1792180-81-4 |
利特昔替尼
Ritlecitinib
-
98+%
|
需询价 |
C15H19N5O |
|
|
|
| CL2693A |
|
2192215-81-7 |
利特昔替尼对甲苯磺酸盐
Ritlecitinib Tosylate
-
98+%
|
需询价 |
C22H27N5O4S |
|
|
|
| CL2655 |
|
1263774-59-9 |
迪高替尼
Delgocitinib | JTE-052 | Corectim
-
98+%
|
需询价 |
C16H18N6O |
|
|
|
| CL2547 |
|
83280-65-3 |
2-乙酰基呋喃并-1,4-萘醌
Napabucasin(BBI608)
3-5days
98+%
|
￥450.00 |
C14H8O4 |
|
|
|
| CL2531 |
|
1640292-55-2 |
奥拉替尼马来酸盐 (1208319-27-0)
Oclacitinib Maleate (PF-03394197 Maleate)
3-5days
98+%
|
￥650.00 |
C19H27N5O6S |
|
|
|
| CL2506 |
|
40391-99-9 |
|
需询价 |
C3H11NO7P2 |
|
|
|
| CL1014B |
|
485-19-8 |
牛心果碱，网状番荔枝碱
Reticuline
3-5days
98+%
|
￥2800.00 |
C19H23NO4 |
|
|
|
| CL2425 |
|
425386-60-3 |
司马西特
Semagacestat (LY450139)
-
98+%
|
需询价 |
C19H27N3O4 |
|
|
|
| CLA1355 |
|
1447814-75-6 |
布隆妥珠单抗
Brontictuzumab (Anti-NOTCH1)
3-5days
95+%
|
￥3200.00 |
— |
|
|
|
| CLA1337 |
|
1345009-45-1 |
万替妥单抗
Vantictumab (Anti-FZD)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1334 |
|
1359940-55-8 |
他瑞妥单抗
Tarextumab (Anti-NOTCH3)
3-5days
95+%
|
￥2200.00 |
— |
|
|
|
| CLA1299 |
|
1243262-17-0 |
登赛珠单抗
Demcizumab (Anti-DLL4)
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CL2221 |
|
1226056-71-8 |
Thiazovivin
Thiazovivin
3-5days
98+%
|
￥700.00 |
C15H13N5OS |
|
|
|
| HL1389 |
|
88495-63-0 |
青蒿琥酯; 青蒿脂
Artesunate
In-stock
98+%
|
￥200.00 |
C19H28O8 |
|
|
|
